Study of the spectrum of bile acids in patients with non-alcoholic fatty liver disease in combination with hyperuricemia

Authors: A.S. Svintsitskyi, N.P. Kozak, I.V. Korendovych, O.V. Barabanchyk, National Medical University named after O.O. Bogomoletsa, Kyiv


Summary

The article presents the results of a study of bile colloidal properties and biochemical parameters of liver functional state and lipid metabolism in patients with nonalcoholic fatty liver disease combined with hyperuricemia. In patients with hyperuricemia, the increased levels of cholic and deoxycholic acids and the decreased level of taurocholic acid were more frequently observed. Imbalance between these parameters and shift of bile pH to the acid side increase bile lithogenic properties, that contributes to the formation of gallstones. The use of ursodeoxycholic acid, rosuvastatin, and allopurinol in these patients improves clinical symptoms, normalizes biochemical parameters of liver functional state and lipid metabolism and also the spectrum of bile acids.

Keywords: nonalcoholic fatty liver disease, hyperuricemia, biliary sludge, bile acids, ursodeoxycholic acid.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design